| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 575.18 | 514.62 | 322.35 | 355.07 |
yoy growth (%) | 11.76 | 59.64 | -9.21 | -5.42 |
Raw materials | -375.96 | -336.68 | -176.8 | -205.42 |
As % of sales | 65.36 | 65.42 | 54.84 | 57.85 |
Employee costs | -43.74 | -35.88 | -33.78 | -27.82 |
As % of sales | 7.6 | 6.97 | 10.48 | 7.83 |
Other costs | -86.64 | -95.18 | -68.69 | -78.26 |
As % of sales (Other Cost) | 15.06 | 18.49 | 21.31 | 22.04 |
Operating profit | 68.82 | 46.86 | 43.06 | 43.56 |
OPM | 11.96 | 9.1 | 13.35 | 12.26 |
Depreciation | -32.57 | -34.28 | -31.05 | -32.72 |
Interest expense | 0 | -12.72 | -13.04 | -34.97 |
Other income | 8.42 | 17.76 | 3.57 | 0.72 |
Profit before tax | 44.67 | 17.61 | 2.54 | -23.42 |
Taxes | 4.31 | 13.21 | -1.96 | -3.16 |
Tax rate | 9.66 | 74.98 | -77.04 | 13.49 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 48.98 | 30.83 | 0.58 | -26.58 |
Exceptional items | 0 | 23.44 | -8.81 | 0 |
Net profit | 48.98 | 54.27 | -8.22 | -26.58 |
yoy growth (%) | -9.73 | -759.69 | -69.05 | 31.32 |
NPM | 8.51 | 10.54 | -2.55 | -7.48 |
The company is now set to further expand into Eastern Europe as this recognition ensures patients and healthcare providers have access to reliable and effective antibiotics.
Furthermore, the NPRA's recognition will enable Venus Remedies to capitalise on the expanding global demand for enoxaparin.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
